Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 86(5): 745-752, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22556069

RESUMEN

Dengue, endemic in Puerto Rico, reached a record high in 2010. To inform policy makers, we derived annual economic cost. We assessed direct and indirect costs of hospitalized and ambulatory dengue illness in 2010 dollars through surveillance data and interviews with 100 laboratory-confirmed dengue patients treated in 2008-2010. We corrected for underreporting by using setting-specific expansion factors. Work absenteeism because of a dengue episode exceeded the absenteeism for an episode of influenza or acute otitis media. From 2002 to 2010, the aggregate annual cost of dengue illness averaged $38.7 million, of which 70% was for adults (age 15+ years). Hospitalized patients accounted for 63% of the cost of dengue illness, and fatal cases represented an additional 17%. Households funded 48% of dengue illness cost, the government funded 24%, insurance funded 22%, and employers funded 7%. Including dengue surveillance and vector control activities, the overall annual cost of dengue was $46.45 million ($12.47 per capita).


Asunto(s)
Costo de Enfermedad , Dengue/economía , Dengue/epidemiología , Hospitalización/economía , Adulto , Instituciones de Atención Ambulatoria/economía , Niño , Costos y Análisis de Costo , Humanos , Puerto Rico/epidemiología
2.
Am J Trop Med Hyg ; 84(2): 200-7, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21292885

RESUMEN

The growing burden of dengue in endemic countries and outbreaks in previously unaffected countries stress the need to assess the economic impact of this disease. This paper synthesizes existing studies to calculate the economic burden of dengue illness in the Americas from a societal perspective. Major data sources include national case reporting data from 2000 to 2007, prospective cost of illness studies, and analyses quantifying underreporting in national routine surveillance systems. Dengue illness in the Americas was estimated to cost $2.1 billion per year on average (in 2010 US dollars), with a range of $1-4 billion in sensitivity analyses and substantial year to year variation. The results highlight the substantial economic burden from dengue in the Americas. The burden for dengue exceeds that from other viral illnesses, such as human papillomavirus (HPV) or rotavirus. Because this study does not include some components (e.g., vector control), it may still underestimate total economic consequences of dengue.


Asunto(s)
Dengue/economía , Región del Caribe/epidemiología , América Central/epidemiología , Costo de Enfermedad , Dengue/epidemiología , Costos de la Atención en Salud/estadística & datos numéricos , Humanos , América del Sur/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA